FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

870711000001107: Pro-Banthine 15mg tablets (Concord Pharmaceutical Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17114701000001117 Pro-Banthine 15mg tablets (Concord Pharmaceutical Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
100608401000001116 Pro-Banthine 15mg tablets (Kyowa Kirin Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Pro-Banthine 15mg tablets (Concord Pharmaceutical Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Pro-Banthine 15mg tablets (Concord Pharmaceutical Ltd) Is a Product containing precisely propantheline bromide 15 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Pro-Banthine 15mg tablets (Concord Pharmaceutical Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Pro-Banthine 15mg tablets (Concord Pharmaceutical Ltd) Has excipient Beeswax true Inferred relationship Existential restriction modifier
Pro-Banthine 15mg tablets (Concord Pharmaceutical Ltd) Has active ingredient Propantheline bromide false Inferred relationship Existential restriction modifier
Pro-Banthine 15mg tablets (Concord Pharmaceutical Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Pro-Banthine 15mg tablets (Concord Pharmaceutical Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Pro-Banthine 15mg tablets (Concord Pharmaceutical Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Pro-Banthine 15mg tablets (Concord Pharmaceutical Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Pro-Banthine 15mg tablets (Concord Pharmaceutical Ltd) Is a Pro-Banthine true Inferred relationship Existential restriction modifier
Pro-Banthine 15mg tablets (Concord Pharmaceutical Ltd) Has specific active ingredient Propantheline bromide true Inferred relationship Existential restriction modifier
Pro-Banthine 15mg tablets (Concord Pharmaceutical Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Pro-Banthine 15mg tablets (Concord Pharmaceutical Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Pro-Banthine 15mg tablets (Concord Pharmaceutical Ltd) 112 tablet 4 x 28 tablets Is pack of False Pro-Banthine 15mg tablets (Concord Pharmaceutical Ltd) Inferred relationship Existential restriction modifier
Pro-Banthine 15mg tablets (Concord Pharmaceutical Ltd) 112 tablet 4 x 28 tablets Has AMP True Pro-Banthine 15mg tablets (Concord Pharmaceutical Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start